We create minimally invasive medical technology addressing patient needs from diagnosis to therapy.

“We Think Big by Creating Small”

Message from TransMed7, LLC President, Dr. Edgar Staren:

Please note:  The SpeedBird family of devices has received 510(k) clearance by FDA.  The Concorde and Cardinal families of devices are not yet commercially available.

September 18, 2018:  TransMed7, LLC announced today the availability of Concorde, the stereotactic table variant of its SpeedBird Biopsy Device Platform.  “We are delighted to announce a letter-to-file regarding ConcordeTM, the stereotactic table variant of our FDA-cleared SpeedBirdTM soft tissue biopsy device platform,” stated Dr. James W. Vetter, TransMed7 Co-Founder and Chairman. “Like the original announcement on June 19 that the FDA had cleared our 510(k) application to market SpeedBird, this is another important step as it furthers TransMed7’s goal of developing, under the guidance of experts, critically needed, simpler to use, minimally-invasive medical technologies and distributing them into the hands of clinicians for the benefit of their patients.”  …read more…


Further Company Information